SG11201400919RA - Patient stratification and determining clinical outcome for cancer patients - Google Patents

Patient stratification and determining clinical outcome for cancer patients

Info

Publication number
SG11201400919RA
SG11201400919RA SG11201400919RA SG11201400919RA SG11201400919RA SG 11201400919R A SG11201400919R A SG 11201400919RA SG 11201400919R A SG11201400919R A SG 11201400919RA SG 11201400919R A SG11201400919R A SG 11201400919RA SG 11201400919R A SG11201400919R A SG 11201400919RA
Authority
SG
Singapore
Prior art keywords
cancer patients
clinical outcome
patient stratification
determining clinical
determining
Prior art date
Application number
SG11201400919RA
Inventor
Jean Paul Thiery
Yun-Ju Ruby Huang
Kian Ngiap Chua
Wen Jing Sim
Seiichi Mori
Original Assignee
Agency Science Tech & Res
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res, Univ Singapore filed Critical Agency Science Tech & Res
Publication of SG11201400919RA publication Critical patent/SG11201400919RA/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201400919RA 2011-09-23 2012-09-24 Patient stratification and determining clinical outcome for cancer patients SG11201400919RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161538487P 2011-09-23 2011-09-23
PCT/SG2012/000354 WO2013043132A1 (en) 2011-09-23 2012-09-24 Patient stratification and determining clinical outcome for cancer patients

Publications (1)

Publication Number Publication Date
SG11201400919RA true SG11201400919RA (en) 2014-10-30

Family

ID=47914688

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201400919RA SG11201400919RA (en) 2011-09-23 2012-09-24 Patient stratification and determining clinical outcome for cancer patients

Country Status (3)

Country Link
US (1) US9953129B2 (en)
SG (1) SG11201400919RA (en)
WO (1) WO2013043132A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201400919RA (en) 2011-09-23 2014-10-30 Agency Science Tech & Res Patient stratification and determining clinical outcome for cancer patients
US20150267259A1 (en) * 2012-10-12 2015-09-24 Agency For Science, Technology And Research Method of prognosis and stratification of ovarian cancer
EP3143530B1 (en) 2014-05-16 2019-03-27 Brainlab AG Inference transparency system for image-based clinical decision support systems
EP3455761B1 (en) * 2016-05-10 2021-12-22 Mayo Foundation for Medical Education and Research Methods and materials for staging and treating skin cancer
US9725769B1 (en) * 2016-10-07 2017-08-08 Oncology Venture ApS Methods for predicting drug responsiveness in cancer patients
US10977794B2 (en) * 2018-01-04 2021-04-13 Ohio State Innovation Foundation Automated identification of tumor buds
JP2022513024A (en) * 2018-11-12 2022-02-07 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ Methods for Manipulating Cancer Cell State Transition
CN112168820B (en) * 2019-07-05 2023-09-29 中国科学院生物物理研究所 Application of SRCAP ATPase inhibitor in colorectal cancer treatment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060078941A1 (en) 2003-06-09 2006-04-13 Santin Alessandro D Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
WO2005083128A2 (en) 2004-02-25 2005-09-09 University Of South Florida Methods for predicting cancer outcome and gene signatures for use therein
US20070231822A1 (en) * 2006-02-28 2007-10-04 Michael Mitas Methods for the detection and treatment of cancer
EP2094719A4 (en) 2006-12-19 2010-01-06 Genego Inc Novel methods for functional analysis of high-throughput experimental data and gene groups identified therfrom
AU2008307579A1 (en) 2007-10-03 2009-04-09 Osi Pharmaceuticals, Inc. Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
WO2009111067A2 (en) 2008-03-07 2009-09-11 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal -like tumor cells or their formation
US9127078B2 (en) * 2008-07-21 2015-09-08 The Trustees Of The University Of Pennsylvania Methods and compositions using splicing regulatory proteins involved in tumor suppression
EP2425015B1 (en) * 2009-04-29 2018-01-10 Ralph Wirtz A method to assess prognosis and to predict therapeutic success in cancer by determining hormone receptor expression levels
WO2011044513A1 (en) 2009-10-08 2011-04-14 Wake Forest University Health Sciences Diagnostic and prognostic markers for cancer
US20140031251A1 (en) * 2010-11-03 2014-01-30 H. Lee Moffitt Cancer Center And Research Institute, Inc. Methods of classifying human subjects with regard to cancer prognosis
SG11201400919RA (en) 2011-09-23 2014-10-30 Agency Science Tech & Res Patient stratification and determining clinical outcome for cancer patients

Also Published As

Publication number Publication date
US9953129B2 (en) 2018-04-24
US20140236495A1 (en) 2014-08-21
WO2013043132A1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
AP2013007178A0 (en) BCMA-based stratification and therapy for multiplemyeloma patients
IL233709A (en) Method of predicting a likelihood of clinical outcome for a patient with prostate cancer
SG11201400919RA (en) Patient stratification and determining clinical outcome for cancer patients
HUE051674T2 (en) Means and methods for the prediction of treatment response of a cancer patient
PT2426148E (en) Anti-il-3ra antibody for use in treatment of blood tumor
IL219978A0 (en) Method to use gene expresssion to determine likelihood of clinical outcome of renal cancer
EP2788752A4 (en) Method of therapy selection for patients with cancer
EP2539704A4 (en) Cancer patient selection for administration of therapeutic agents using mass spectral analysis
ZA201300218B (en) Treatment of blood cancer
EP2606349A4 (en) Cancer diagnostic and cancer therapeutic
HK1217093A1 (en) Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
EP2668504A4 (en) Predictive test for selection of metastatic breast cancer patients for hormonal and combination therapy
EP2700652A4 (en) Diagnosis and treatment of cancer using anti-itm2a antibody
EP2614375A4 (en) Combination methods of diagnosing cancer in a patient
EP2633063A4 (en) Cancer imaging with therapy: theranostics
IL232656A0 (en) Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer
HRP20170220T1 (en) Therapeutic and diagnostic target
EP2619332A4 (en) Direct blood assay for detection of circulating microrna in cancer patients
PL2726880T3 (en) Treatment of prostate cancer and a method for determining the prognosis for prostate cancer patients
EP2785870A4 (en) Smyd2 as a target gene for cancer therapy and diagnosis
EP2556379A4 (en) New diagnostic and therapeutic target
GB201014042D0 (en) Clinical radiotherapy apparatus
GB201118745D0 (en) Therapeutic and diagnostic target
GB201118275D0 (en) Therapeutic and diagnostic target
GB201112595D0 (en) Therapeutic and diagnostic target